Joan C. Walterscheid, RN, CDE Registered Nurse - Diabetes Educator Medicare: Not Enrolled in Medicare Practice Location: 16810 West Hwy 82, Muenster, TX 76252 Phone: 940-759-4296 Fax: 940-759-4296 |
News Archive
Since the start of the military conflicts in Iraq and Afghanistan, more than 300,000 soldiers have returned to the United States with traumatic brain injury caused by exposure to bomb blasts - and in particular, exposure to improvised explosive devices, or IEDs. Symptoms of traumatic brain injury can range from the mild, such as lingering headaches and nausea, to more severe impairments in memory and cognition.
South Sudan's first unified basic sign language and sign language dictionary will be officially launched and presented in the capital city Juba on Thursday.
In the current issue of Cardiovascular Innovations and Applications volume 4, issue 1, pp. 31-42(12) ; DOI https://doi.org/10.15212/CVIA.2019.0003, Talal Alzahrani, MD, Ahmed Tashkandi, MD, Abdullah Sarkar, MD, Claudio Smuclovisky, MD, James P. Earls, MD and Andrew D. Choi, MD, from the Division of Cardiology, The George Washington University School of Medicine, Washington, DC, USA; Department of Medicine, University of Miami, Miami, FL, USA; Diagnostic Imaging Center, Holy Cross Hospital, Fort Lauderdale, FL, USA and the Department of Radiology, The George Washington University School of Medicine, Washington, DC, USA consider practical clinical applications of cardiac computed tomography-derived fractional flow reserve.
PURE Bioscience, Inc., creator of the patented silver dihydrogen citrate (SDC) antimicrobial, today announced that Health Canada has approved PUREā¢ Hard Surface disinfectant for use in food premises, hospitals and health care facilities, domestic locations and institutional and industrial premises.
Alkermes plc today announced topline results from a phase 2b dose-ranging clinical study of ALKS 37 in the treatment of opioid-induced constipation. The multicenter, randomized, double-blind, placebo-controlled, repeat-dose study was designed to assess the safety, tolerability, pharmacokinetic profile and efficacy of ALKS 37 in approximately 150 patients.
› Verified 7 days ago